These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 8904892)
1. A role for paclitaxel in the combination chemotherapy of acute myeloblastic leukaemia: preclinical cell culture studies. Curtis JE; Minkin S; Minden MD; McCulloch EA Br J Haematol; 1996 Nov; 95(2):354-63. PubMed ID: 8904892 [TBL] [Abstract][Full Text] [Related]
2. OCI/AML-4 an acute myeloblastic leukemia cell line: regulation and response to cytosine arabinoside. Koistinen P; Wang C; Yang GS; Wang YF; Williams DE; Lyman SD; Minden MD; McCulloch EA Leukemia; 1991 Aug; 5(8):704-11. PubMed ID: 1715961 [TBL] [Abstract][Full Text] [Related]
3. Post-transcriptional regulation of bcl-2 in acute myeloblastic leukemia: significance for response to chemotherapy. Hu ZB; Minden MD; McCulloch EA Leukemia; 1996 Mar; 10(3):410-6. PubMed ID: 8642855 [TBL] [Abstract][Full Text] [Related]
4. Influence of schedule on regulated sensitivity of AML blasts to cytosine arabinoside. Yang GS; Minden MD; McCulloch EA Leukemia; 1993 Jul; 7(7):1012-9. PubMed ID: 7686602 [TBL] [Abstract][Full Text] [Related]
5. In vitro response of blasts to IL-3, GM-CSF, and G-CSF is different for individual AML patients: factors that stimulate leukemic clonogenic cells also enhance Ara-C cytotoxicity. Van der Lely N; De Witte T; Wessels J; Raymakers R; Muus P; Preijers F Ann Hematol; 1994 May; 68(5):225-32. PubMed ID: 7517190 [TBL] [Abstract][Full Text] [Related]
6. Enhanced chemosensitivity of clonogenic blasts from patients with acute myeloid leukemia by G-CSF, IL-3 or GM-CSF stimulation. te Boekhorst PA; Löwenberg B; Vlastuin M; Sonneveld P Leukemia; 1993 Aug; 7(8):1191-8. PubMed ID: 7688839 [TBL] [Abstract][Full Text] [Related]
7. Granulocyte-macrophage colony-stimulating factor and interleukin-3 protect leukemic blast cells from ara-C toxicity. Koistinen P; Wang C; Curtis JE; McCulloch EA Leukemia; 1991 Sep; 5(9):789-95. PubMed ID: 1719308 [TBL] [Abstract][Full Text] [Related]
8. Cytosine arabinoside (ara-C) and cis-dichlorodiammineplatinum II (cisplatin) alone and in combination: effects on acute myeloblastic leukemia blast cells in culture and in vivo. Wang YF; Curtis JE; Lipton J; Minkin S; McCulloch EA Leukemia; 1991 Jun; 5(6):522-7. PubMed ID: 1711641 [TBL] [Abstract][Full Text] [Related]
9. Mechanism of cytosine arabinoside toxicity to the blast cells of acute myeloblastic leukemia: involvement of free radicals. Hu ZB; Yang GS; Li M; Miyamoto N; Minden MD; McCulloch EA Leukemia; 1995 May; 9(5):789-98. PubMed ID: 7769841 [TBL] [Abstract][Full Text] [Related]
10. Regulation by retinoic acid and hydrocortisone of the anthracycline sensitivity of blast cells of acute myeloblastic leukemia. Yang GS; Minden MD; McCulloch EA Leukemia; 1994 Dec; 8(12):2065-75. PubMed ID: 7807996 [TBL] [Abstract][Full Text] [Related]
11. Enhancement of cytosine arabinoside cytotoxicity by granulocyte/macrophage colony-stimulating factor and granulocyte colony-stimulating factor in a human myeloblastic leukemia cell line. Takauji R; Tohyama K; Ueda T; Nakamura T Jpn J Cancer Res; 1993 Apr; 84(4):445-50. PubMed ID: 7685751 [TBL] [Abstract][Full Text] [Related]
12. Response of the blast stem cells of acute myeloblastic leukemia to G-CSF, GM-CSF, or the ligand for C-KIT, alone or in combination. McCulloch EA; Minkin S; Curtis JE; Minden MD Hematopathol Mol Hematol; 1996; 10(3):111-22. PubMed ID: 8878730 [TBL] [Abstract][Full Text] [Related]
13. Hematopoietic growth factor stimulation and cytarabine cytotoxicity in vitro: effects in untreated and relapsed or primary refractory acute myeloid leukemia cells. te Boekhorst PA; Löwenberg B; Sonneveld P Leukemia; 1994 Sep; 8(9):1480-6. PubMed ID: 7522289 [TBL] [Abstract][Full Text] [Related]
14. Contrasting in vitro effects for the combination of fludarabine, cytosine arabinoside (Ara-C) and granulocyte colony-stimulating factor (FLAG) compared with daunorubicin and Ara-C in P-glycoprotein-positive and P-glycoprotein-negative acute myeloblastic leukaemia. Higashi Y; Turzanski J; Pallis M; Russell NH Br J Haematol; 2000 Nov; 111(2):565-9. PubMed ID: 11122104 [TBL] [Abstract][Full Text] [Related]
15. Effects of interleukin-6 and granulocyte colony-stimulating factor on the proliferation of leukemic blast progenitors from acute myeloblastic leukemia patients. Suzuki T; Morio T; Tohda S; Nagata K; Yamashita Y; Imai Y; Aoki N; Hirashima K; Nara N Jpn J Cancer Res; 1990 Oct; 81(10):979-86. PubMed ID: 1699919 [TBL] [Abstract][Full Text] [Related]
16. Modulation of the cellular metabolism of cytarabine and fludarabine by granulocyte-colony-stimulating factor during therapy of acute myelogenous leukemia. Gandhi V; Estey E; Du M; Nowak B; Keating MJ; Plunkett W Clin Cancer Res; 1995 Feb; 1(2):169-78. PubMed ID: 9815970 [TBL] [Abstract][Full Text] [Related]
17. Effect of a combined exposure to cytosine arabinoside, bryostatin 1, and recombinant granulocyte-macrophage colony-stimulating factor on the clonogenic growth in vitro of normal and leukemic human hematopoietic progenitor cells. Grant S; Traylor R; Bhalla K; McCrady C; Pettit GR Leukemia; 1992 May; 6(5):432-9. PubMed ID: 1593908 [TBL] [Abstract][Full Text] [Related]
18. Blast cell proliferative activity and sensitivity to GM-CSF in vitro are associated with early response to TAD-9 induction therapy in acute myeloid leukemia. Jahns-Streubel G; Reuter C; Unterhalt M; Schleyer E; Wörmann B; Büchner T; Hiddemann W Leukemia; 1995 Nov; 9(11):1857-63. PubMed ID: 7475275 [TBL] [Abstract][Full Text] [Related]
19. All-trans retinoic acid potentiates megakaryocyte colony formation: in vitro and in vivo effects after administration to acute promyelocytic leukemia patients. Visani G; Zauli G; Tosi P; Ottaviani E; Gibellini D; Manfroi S; Celeghini C; Pagliarini C; Bassini A; Tura S Leukemia; 1994 Dec; 8(12):2183-7. PubMed ID: 7528859 [TBL] [Abstract][Full Text] [Related]
20. Relationship between the in vitro sensitivity to cytosine arabinoside of blast progenitors and the outcome of treatment in acute myeloblastic leukaemia patients. Nara N; Suzuki T; Nagata K; Yamashita Y; Murohashi I; Adachi Y Br J Haematol; 1988 Oct; 70(2):187-91. PubMed ID: 3191030 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]